Clinical Scorecard: Case Study: Discovery of the uncommon H3-3A p.G35W mutation in an adolescent with low-grade glioma of the tectal plate

At a Glance

Key Highlights

• Identification of H3-3A p.G35W mutation in a pilocytic astrocytoma and its unclear implications for tumor behavior
• Methylation profiling aids in understanding tumor behavior
• Tectal plate gliomas are rare and often present with raised intracranial pressure
• Management focuses on symptomatic treatment rather than direct tumor therapy
• Favorable overall survival rates in pediatric low-grade gliomas

Guideline-Based Recommendations

Diagnosis

• Utilize imaging and molecular diagnostics for accurate classification
• Consider biopsy for histological confirmation in symptomatic cases

Management

• Prioritize CSF diversion procedures for obstructive hydrocephalus
• Consider early surgical intervention if feasible
• Incorporate molecular profiling in treatment planning

Monitoring & Follow-up

• Regular follow-up with imaging to assess for tumor progression
• Close surveillance of symptoms related to intracranial pressure

Risks

• Potential for obstructive hydrocephalus and associated complications
• Uncertainty regarding the oncogenic potential of H3-3A p.G35W mutation

Patient & Prescribing Data

Focus on symptomatic management and monitoring rather than aggressive treatment, considering risks associated with the H3-3A mutation

Clinical Best Practices

• Incorporate molecular profiling in the management of pediatric gliomas
• Educate families about the indolent nature of tectal plate gliomas
• Utilize a multidisciplinary approach for treatment planning, emphasizing collaboration among specialists

References

• WHO Classification of Tumours of the Central Nervous System
• Molecular diagnostics in pediatric gliomas